Trial intelligence / Profile preview

Probiotics for Nosocomial Infections in Preterm Neonates

NCT01340469Phase 3Completed

Start
Jan 2005
Primary completion
Mar 2008
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of Infloran in nosocomial infection, necrotizing enterocolitis (NEC). Started Jan 2005; status: completed.

02

Drugs

Infloran
03

Conditions

nosocomial infectionnecrotizing enterocolitis (NEC)

Beyond the preview

Go deeper on NCT01340469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01340469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call